Concurrently, our research implicates AA, an ingredient derived from traditional Chinese medicine, as a prospective renoprotective agent, with its mechanism of action possibly entailing the upregulation of STBD1 to rectify the dysregulated renal metabolism associated with DKD. This evidence concerns the gene STBD1 and diabetic kidney disease.